Pfizer shares sink after it resets 2024 COVID expectations
By Leroy Leo and Michael Erman (Reuters) -Pfizer on Wednesday forecast 2024 sales that could be as much as $5…
By Leroy Leo and Michael Erman (Reuters) -Pfizer on Wednesday forecast 2024 sales that could be as much as $5…
By Stephen Culp NEW YORK (Reuters) -U.S. stocks surged to a sharply higher close on Wednesday and benchmark Treasury yields…
By Scott DiSavino NEW YORK (Reuters) -Oil prices edged up about 1% on Wednesday from a five-month low in the…
By Deena Beasley (Reuters) – Some patients with type 2 diabetes say they are having more difficulty getting reimbursed for…
By Saqib Iqbal Ahmed NEW YORK (Reuters) -Dealers squaring their books ahead of an options expiration that is set to…